Filings Show Elite Hedge Funds Are Investing In These 2 Stocks

Page 2 of 2

The other freshly-amended 13D filed with the SEC disclosed that Clint Carlson’s Carlson Capital holds a stake of 2.05 million shares in Vitamin Shoppe Inc. (NYSE:VSI), representing 6.94% of the company’s common stock. This marks a lift of 185,709 shares from the position the fund disclosed in its 13F filing for the June quarter. The shares of the multi-channel specialty retailer of nutritional products have been on a steady decline this year, losing more than 33% year-to-date. The company’s same-store sales growth has been weakening over the past few years, which has put some weight on the stock performance. At the same time, Vitamin Shoppe Inc. (NYSE:VSI) has been finding it troublesome to integrate its acquisition of vitamins, minerals and supplements (VMS) manufacturer FDC Vitamins LLC, which was purchased in June of last year for roughly $85 million. Even so, Vitamin Shoppe received some attention from the hedge fund industry during the second quarter, as the number of investors in our database which were invested in the stock increased to 20 from 15 quarter-over-quarter. Similarly, the value of their investments increased to $273.22 million from $179.84 million. Jamie Zimmerman’s Litespeed Management added a 781,810-share position in Vitamin Shoppe Inc. (NYSE:VSI) to its portfolio during the second quarter.

Follow Vitamin Shoppe Inc. (NYSE:VSI)

Disclosure: None

Page 2 of 2